Lipocine Stock Price (NASDAQ:LPCN)

Add to My Stocks
$1.57 $0.01 (0.63%) LPCN stock closing price Sep 19, 2018 (Closing)
Prev Close* : $1.58
Market Cap:
$33.49M
Day Low: $1.52
52 Week Low: $1.03
Open: $1.57
Volume: -
Day High: $1.6
52 Week High: $4.38
Dividend:
0.00

Latest Stock Market News

Latest Articles

Lipocine News - From Partners

LPCN Stockcharts

View LPCN PE ratio, PS ratio stocks charts and compare with peers.
LPCN Chart
Note: Compare Lipocine stock price history with the index and industry peers.

Lipocine Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Lipocine Returns

ROE
(return on equity)

Lipocine Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

LPCN Industry Peers

Company Price Change (%)
Plx Pharma Inc (PLXP)4.230.12 (2.76%)
India Globalization Capital (IGC)1.690.28 (19.86%)
Amag Pharma (AMAG)20.70.25 (1.19%)
Abbvie (ABBV)91.021.59 (1.72%)
Eli Lilly (LLY)105.741.14 (1.07%)
Amneal Pharmact (AMRX)23.80.34 (1.45%)
Antares Pharma (ATRS)3.30.06 (1.79%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Lipocine Inc Stock News - Partner Headlines

Lipocine Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-20.98M-18.97M-18.2M-20.37M-10.59M
Total Operating Expense21.21M19.18M18.38M20.47M10.68M
View Lipocine income statement
balance sheet20172016201520142013
Total Assets25.32M27.34M45.37M27.99M46.1M
Total Liabilities6.34M1.32M3.39M1.63M1.28M
Shareholders Equity18.97M26.01M41.98M26.35M44.82M
View Lipocine balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities1.63M-1.93M1.49M1.16M-
Net Cash from (used by) Operating Activities-16.7M-18.28M-15.35M-17.3M-8.58M
Increase (Decrease) in Prop Plant And Equipment--0.05M-0.02M-0.05M-
View Lipocine cash flow statement

Lipocine Stock Message Board

Lipocine stock lost 0.63%, and the last close price as of Sep 19, 2018 is $1.57 for LPCN stock. Lipocine market capitalization is $33.49M and it represents the total market value of LPCN stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Lipocine stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Lipocine is worth a lot, it will most likely be reflected in an inflated Lipocine stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 60,230 on the last trading day, as is evident from Lipocine stock chart, and LPCN stock quote data. Lipocine paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Lipocine stock price history.